Results 271 to 280 of about 122,153 (397)
Cannabis and cannabinoids in dermatology: a systematic review and meta-analysis of quantitative outcomes. [PDF]
Sermsaksasithorn P +4 more
europepmc +1 more source
ABSTRACT Introduction Washington state's adult use cannabis market operates under regulations by the Washington State Liquor and Cannabis Board to restrict access and promotion among young people. Cannabis edibles sold in the state are required to contain specific labels that inform consumers that the product contains cannabis and provide contact ...
Jessica Fitts Willoughby +7 more
wiley +1 more source
Phytochemical Profile, Extraction and Characterization of Bioactive Compounds from Industrial Hemp (<i>Cannabis sativa</i> L.) Felina 32 Variety. [PDF]
Haczkiewicz M +4 more
europepmc +1 more source
ABSTRACT Issues In Australia, detections of novel benzodiazepines (NBZ) and related overdoses have increased markedly over the last five years. This review summarises Australian peer‐reviewed literature and NBZ‐related drug alerts, outlines the pharmacology of commonly detected NBZs and discusses approaches to harm reduction, managing toxicity ...
Jack Freestone +13 more
wiley +1 more source
Correction: Xiong et al., A Common Molecular Basis for Exogenous and Endogenous Cannabinoid Potentiation of Glycine Receptors [PDF]
Wei Xiong +6 more
openalex +1 more source
Cannabidiol in pancreatic ductal adenocarcinoma: preclinical evidence, molecular mechanisms, and translational challenges. [PDF]
Esmaeli M +2 more
europepmc +1 more source
Resolvin D2 is a specialized pro‐resolving mediator transducing atheroprotective effects on myeloid cells through the GPR18 receptor. This study provides the first evidence that GPR18: Is critical for maintaining endothelial function in muscular, but not elastic, arteries.
Sofie de Moudt +8 more
wiley +1 more source
Immune and glial cell alterations in the rat brain after repeated exposure to the synthetic cannabinoid JWH-018 [PDF]
Nicholas Pintori +6 more
openalex +1 more source
Abstract Hemp (Cannabis sativa L.) was re‐legalized as an agricultural crop through the USDA 2018 Farm Bill, but cropping guidelines remain limited, especially for floral hemp grown for cannabinoid extraction. In this study, the response of direct‐seeded, field‐grown autoflower and full‐season hemp cultivars to varying rates of applied irrigation was ...
Richard J. Roseberg +2 more
wiley +1 more source

